Bharat Biotech to Cut MOSQIVAC Malaria Vaccine Price by 40% Under Gavi-UNICEF Deal
Bharat Biotech will lower the price of its RTS,S malaria vaccine MOSQIVAC from €9.30 to €5.50 a dose from early 2027 under a UNICEF-executed, Gavi-backed agreement expected to save about US$50 million for immunisation programmes.
